SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing heightened volatility and intense trader interest as it joins the S&P 500 index, a move that is triggering mandatory institutional buying and significant market-making activity. The community remains sharply divided, with bulls pointing to the company's critical role in the AI optics supply chain and Nvidia's strategic investment, while bears warn of stretched valuations and risks stemming from shifting industry preferences toward copper technologies.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest following the major regulatory approval of its Alpha DaRT cancer treatment in Japan, a key milestone that serves as a global validator for its oncology platform. The community is actively discussing the company's strong clinical trial progress, robust cash position, and the potential for upcoming milestones to drive the stock toward its analyst-set price targets.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is capturing significant community attention as it secures strategic government contracts and deepens its collaboration with NVIDIA, leading investors to view it as a compelling, undervalued alternative to other quantum stocks. While some express frustration with recent price volatility and de-SPAC pressure, many are actively accumulating shares based on a long-term conviction in the companys debt-free balance sheet and its pivotal role in national security and AI integration.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under pressure as investors weigh recent reports of large-scale layoffs against concerns over massive AI infrastructure spending and looming legal challenges. Community sentiment is sharply divided between long-term believers citing the company's valuation and dominant advertising position, and skeptical traders who view recent price action as a technical breakdown signaling further downside risk.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

Community sentiment regarding OpenAI is heavily polarized, with active discussions focusing on both its leadership in AI traffic and the rise of speculative, unofficial crypto assets claiming to provide investment exposure. Investors are also scrutinizing the company's massive capital expenditure requirements and the potential long-term impact of its partnerships on the financial health of major corporate collaborators.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is facing significant volatility as investors debate the viability of the company's turnaround plan, balancing recent traffic improvements against margin pressures and intense competition from faster, value-oriented rivals. The community remains deeply divided, with some betting on a long-term recovery under new leadership while others highlight declining brand loyalty and store closures as indicators of structural trouble.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is in the spotlight as investors react to the appointment of Parks chief Josh D'Amaro as the new CEO, succeeding Bob Iger in a move aimed at revitalizing long-term stock performance. While the community is actively debating the company's future strategy, leadership transition, and ongoing cost-cutting efforts, sentiment remains mixed between those seeking a turnaround and skeptics wary of the stock's recent performance.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing intense downward pressure as institutional investors and the trading community grapple with a broader sector rotation away from software and cybersecurity, exacerbated by speculative concerns regarding the impact of new AI-driven coding tools. While bullish investors argue the sell-off is a fundamental decoupling and a prime buying opportunity for a SASE leader, the stock faces consistent technical selling and heightened short interest from those betting on continued valuation compression.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Takeda Pharmaceutical (NYSE:TAK) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered Takeda Pharmaceutical from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

200,033 Shares in Takeda Pharmaceutical Co. $TAK Acquired by XY Capital Ltd

XY Capital Ltd bought a new stake in shares of Takeda Pharmaceutical Co. (NYSE:TAK - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission...

Takeda Pharmaceutical Co. $TAK Shares Sold by Van ECK Associates Corp

Van ECK Associates Corp cut its stake in shares of Takeda Pharmaceutical Co. (NYSE:TAK - Free Report) by 12.7% in the 3rd quarter, according to the company in its most recent filing with the...

Capital Research Global Investors Buys 108,556 Shares of Takeda Pharmaceutical Co. $TAK

Capital Research Global Investors increased its stake in Takeda Pharmaceutical Co. (NYSE:TAK - Free Report) by 0.8% during the 3rd quarter, according to its most recent disclosure with the Securities...

Denali Gains 11.8% in a Month: Buy, Sell or Hold the Stock? 

DNLI stock jumps as investors eye an April 5, 2026, FDA decision on tividenofusp alfa for Hunter syndrome, a key catalyst for growth.

Fisher Asset Management LLC Lowers Stock Position in Takeda Pharmaceutical Co. $TAK

Fisher Asset Management LLC lessened its position in shares of Takeda Pharmaceutical Co. (NYSE:TAK - Free Report) by 59.0% during the 3rd quarter, according to the company in its most recent...

Takeda Pharmaceutical (NYSE:TAK) Upgraded by Zacks Research to "Hold" Rating

Zacks Research upgraded shares of Takeda Pharmaceutical from a "strong sell" rating to a "hold" rating in a research report on Tuesday...

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (Protagonist) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and...

DNLI Q4 Loss Narrower Than Expected, Hunter Syndrome Drug in Focus

Denali posts narrower-than-expected Q4 loss as FDA extends review of tividenofusp alfa, with $966M cash backing pipeline advances and no Q4 revenues.

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity PR Newswire NEW YORK, Feb. 24, 2026...

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Current Price	$17.83
Prev Close	$18.11
Open	$18.12
Dividend Yield	3.65%
50-Day Moving Average	$17.61
Beta	0.25
Avg. Volume	2.75M
PE Ratio	71.95

52-Week High	$18.82
52-Week Low	$12.99
Market Capitalization	$56.33B
EPS (Annual)	$0.2242
Price to Book	1.16
Revenue Per Employee	$633,289.19

TAK
Takeda Pharmaceutical Co Ltd (ADR)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TAK News

TAKTakeda Pharmaceutical Co Ltd (ADR)